This page presents informaton about Covid-19 treatments and theirs eficacy, based on scientific reasearch and data.

Many of medicines and substances (herbs, spices) listed below are easily available and have been used for hundrets of years to treat infections.

The table below comes from https://c19early.com. Please, visit https://c19early.com for updated information.

Random effects meta-analysis of all studies combined (pooled effects, all stages). Treatments with ≤3 studies with distinct authors or with <50 control events are shown in grey. Pooled results across all stages and outcomes depend on the distribution of stages and outcomes tested – for example late stage treatment may be less effective and if the majority of studies are late stage this may obscure the efficacy of early treatment. Please see the specific stage and outcome analyses. Protocols typically combine multiple treatments which may be complementary and synergistic, and the SOC in studies often includes other treatments.
00.250.50.7511.251.51.752+Molnupiravir89%0.11 [0.01-0.90]2$700964very few trials/eventsCostStudiesPatientsImprovement, RR [CI]Proxalutamide84%0.16 [0.12-0.22]3n/a1,090few trials/eventsIota-carragee..80%0.20 [0.04-0.89]1$1394very few trials/eventsQuercetin72%0.28 [0.07-1.06]4$5736very few trials/eventsPovidone-Iod..71%0.29 [0.16-0.54]7$12,161Nigella Sativa67%0.33 [0.21-0.52]4$51,291few trials/eventsSotrovimab67%0.33 [0.01-8.16]1$2,100583very few trials/eventsIvermectin65%0.35 [0.27-0.43]63$147,461Casirivimab/i..64%0.36 [0.16-0.78]7$2,10024,409Melatonin64%0.36 [0.22-0.58]11$113,517Fluvoxamine63%0.37 [0.09-1.47]3$41,749few trials/eventsCurcumin59%0.41 [0.24-0.70]9$5867few trials/eventsBamlanivimab59%0.41 [0.23-0.74]7$1,2509,136Vitamin A55%0.45 [0.18-1.10]4$2636few trials/eventsNitazoxanide55%0.45 [0.15-1.35]6$41,464Zinc51%0.49 [0.38-0.62]17$134,906Budesonide45%0.55 [0.31-0.98]3$48,751few trials/eventsBromhexine45%0.55 [0.40-0.77]5$5291few trials/eventsVitamin D39%0.61 [0.54-0.69]46$150,552Favipiravir37%0.63 [0.48-0.81]14$203,068Colchicine31%0.69 [0.54-0.88]12$117,762Hydroxychloro..25%0.75 [0.71-0.79]294$1412,766Probiotics20%0.80 [0.69-0.93]12$51,721Aspirin20%0.80 [0.69-0.94]20$165,401Remdesivir19%0.81 [0.73-0.89]24$3,12097,505Metformin15%0.85 [0.73-0.99]7$107,360Vitamin C11%0.89 [0.78-1.01]23$115,499Conv. Plasma-1%1.01 [0.90-1.13]13$5,00014,426All studies combined (pooled effects, all stages)c19early.com Oct 20, 2021Favors treatmentFavors control
Random effects meta-analysis of all studies combined (pooled effects, all stages). Treatments with ≤3 studies with distinct authors or with <50 control events are shown in grey. Pooled results across all stages and outcomes depend on the distribution of stages and outcomes tested – for example late stage treatment may be less effective and if the majority of studies are late stage this may obscure the efficacy of early treatment. Please see the specific stage and outcome analyses. Protocols typically combine multiple treatments which may be complementary and synergistic, and the SOC in studies often includes other treatments.
00.250.50.7511.251.51.752+Fluvoxamine89%0.11 [0.01-0.85]2$4277very few trials/eventsCostStudiesPatientsImprovement, RR [CI]Molnupiravir89%0.11 [0.01-0.90]2$700964very few trials/eventsNigella Sativa84%0.16 [0.05-0.48]3$5915few trials/eventsBudesonide82%0.18 [0.04-0.79]1$4146very few trials/eventsVitamin D81%0.19 [0.10-0.35]6$1912few trials/eventsPovidone-Iod..81%0.19 [0.10-0.37]6$1807few trials/eventsBromhexine79%0.21 [0.06-0.72]2$596very few trials/eventsVitamin A79%0.21 [0.07-0.61]2$2240very few trials/eventsQuercetin79%0.21 [0.02-1.82]2$5194very few trials/eventsMelatonin78%0.22 [0.06-0.75]2$191very few trials/eventsBamlanivimab76%0.24 [0.12-0.50]4$1,2507,389Zinc75%0.25 [0.04-1.71]3$1982very few trials/eventsProxalutamide73%0.27 [0.03-2.39]2n/a445very few trials/eventsCurcumin71%0.29 [0.11-0.74]6$5707few trials/eventsCasirivimab/i..67%0.33 [0.14-0.77]4$2,10012,710few trials/eventsSotrovimab67%0.33 [0.01-8.16]1$2,100583very few trials/eventsIvermectin66%0.34 [0.24-0.48]28$126,458Hydroxychloro..64%0.36 [0.29-0.46]32$154,621Nitazoxanide49%0.51 [0.13-1.95]5$41,414few trials/eventsFavipiravir48%0.52 [0.36-0.76]4$20410very few trials/eventsVitamin C46%0.54 [0.19-1.51]2$1208very few trials/eventsProbiotics34%0.66 [0.55-0.80]2$5323few trials/eventsMetformin-15%1.15 [0.73-1.83]1$10423very few trials/eventsConv. Plasma-93%1.93 [0.47-7.87]3$5,000716very few trials/eventsEarly treatment studies (pooled effects)c19early.com Oct 20, 2021Favors treatmentFavors control
Random effects meta-analysis of early treatment studies (pooled effects). Treatments with ≤3 studies with distinct authors or with <50 control events are shown in grey. Pooled results across all outcomes are affected by the distribution of outcomes tested, please see detail pages for specific outcome analysis. Protocols typically combine multiple treatments which may be complementary and synergistic, and the SOC in studies often includes other treatments.
00.250.50.7511.251.51.752+Molnupiravir89%0.11 [0.01-0.90]2$700964very few trials/eventsCostStudiesPatientsImprovement, RR [CI]Povidone-Iod..88%0.12 [0.03-0.50]1$1606very few trials/eventsNigella Sativa87%0.13 [0.04-0.49]2$5732few trials/eventsBromhexine87%0.13 [0.01-1.23]2$5178very few trials/eventsProxalutamide84%0.16 [0.12-0.22]3n/a1,090few trials/eventsMelatonin79%0.21 [0.08-0.56]4$11,650Curcumin70%0.30 [0.14-0.64]4$5434Casirivimab/i..68%0.32 [0.05-1.90]3$2,10019,616few trials/eventsSotrovimab67%0.33 [0.01-8.16]1$2,100583very few trials/eventsNitazoxanide60%0.40 [0.10-1.58]3$4923very few trials/eventsProbiotics59%0.41 [0.23-0.72]4$5539few trials/eventsBamlanivimab57%0.43 [0.11-1.68]4$1,2507,566Ivermectin55%0.45 [0.33-0.62]25$134,963Vitamin D51%0.49 [0.37-0.66]28$112,116Quercetin46%0.54 [0.12-2.40]3$5623very few trials/eventsVitamin A42%0.58 [0.07-4.59]2$2207few trials/eventsZinc41%0.59 [0.47-0.75]9$110,298Colchicine40%0.60 [0.42-0.86]10$117,373Budesonide39%0.61 [0.22-1.67]1$41,586very few trials/eventsFluvoxamine29%0.71 [0.38-1.30]1$41,472very few trials/eventsHydroxychloro..22%0.78 [0.73-0.83]182$1291,163Aspirin20%0.80 [0.68-0.94]18$154,857Remdesivir19%0.81 [0.73-0.89]23$3,12097,363Vitamin C19%0.81 [0.66-0.99]15$114,063Metformin17%0.83 [0.71-0.97]6$106,937Favipiravir8%0.92 [0.60-1.41]5$202,119Conv. Plasma-1%1.01 [0.90-1.13]13$5,00014,426All mortality results (all stages)c19early.com Oct 20, 2021Favors treatmentFavors control
Random effects meta-analysis of all mortality results (all stages). Treatments with ≤3 studies with distinct authors or with <25 control events are shown in grey. Pooled results across all stages depend on the distribution of stages tested – for example late stage treatment may be less effective and if the majority of studies are late stage this may obscure the efficacy of early treatment. Please see the specific stage analyses. Protocols typically combine multiple treatments which may be complementary and synergistic, and the SOC in studies often includes other treatments.
00.250.50.7511.251.51.752+Bromhexine91%0.09 [0.01-1.59]1$578very few trials/eventsCostStudiesPatientsImprovement, RR [CI]Molnupiravir89%0.11 [0.01-0.90]2$700964very few trials/eventsCasirivimab/i..89%0.11 [0.00-3.00]2$2,1009,831few trials/eventsPovidone-Iod..88%0.12 [0.03-0.50]1$1606very few trials/eventsNigella Sativa87%0.13 [0.04-0.49]2$5732few trials/eventsVitamin A86%0.14 [0.03-0.61]1$2140very few trials/eventsBamlanivimab85%0.15 [0.03-0.77]2$1,2506,784few trials/eventsCurcumin84%0.16 [0.04-0.61]2$5314few trials/eventsZinc79%0.21 [0.03-1.47]1$1518very few trials/eventsQuercetin79%0.21 [0.02-1.82]2$5194very few trials/eventsVitamin D79%0.21 [0.12-0.39]4$1514few trials/eventsHydroxychloro..75%0.25 [0.16-0.40]13$150,628Proxalutamide73%0.27 [0.03-2.39]2n/a445very few trials/eventsSotrovimab67%0.33 [0.01-8.16]1$2,100583very few trials/eventsIvermectin50%0.50 [0.37-0.67]9$124,282Favipiravir45%0.55 [0.05-5.81]1$2092very few trials/eventsNitazoxanide41%0.59 [0.02-13.8]2$4873very few trials/eventsConv. Plasma-93%1.93 [0.47-7.87]3$5,000716very few trials/eventsEarly treatment mortality resultsc19early.com Oct 20, 2021Favors treatmentFavors control
Random effects meta-analysis of early treatment mortality results. Treatments with ≤3 studies with distinct authors or with <25 control events are shown in grey. Protocols typically combine multiple treatments which may be complementary and synergistic, and the SOC in studies often includes other treatments.